Cargando…
Prevalence of Cannabinoid Use in Patients With Hip and Knee Osteoarthritis
INTRODUCTION: State legalization and widespread marketing efforts have increased the accessibility and consumption of off-label, non–FDA-approved, cannabinoid (CBD) products. Although clinical evidence is largely absent for the treatment of musculoskeletal pain, patients are experimenting with these...
Autores principales: | Deckey, David G., Lara, Nina J., Gulbrandsen, Matthew T., Hassebrock, Jeffrey D., Spangehl, Mark J., Bingham, Joshua S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861619/ https://www.ncbi.nlm.nih.gov/pubmed/33986220 http://dx.doi.org/10.5435/JAAOSGlobal-D-20-00172 |
Ejemplares similares
-
Prevalence of Cannabinoid (CBD) Use in Orthopaedic Sports Medicine Patients
por: Deckey, David G., et al.
Publicado: (2022) -
Orthopaedic Residency Applicants' Perspective on Program-Based Social Media
por: Brinkman, Joseph C., et al.
Publicado: (2022) -
Clinical outcomes and survivorship of cementless triathlon total knee arthroplasties: a systematic review
por: Carlson, Brian J., et al.
Publicado: (2022) -
Principles of mechanical and chemical debridement with implant retention
por: Deckey, David G., et al.
Publicado: (2023) -
Increased Risk of Lateral Femoral Cutaneous Nerve Injury in Patients With Previous Hip Arthroscopy Who Underwent a Direct Anterior Approach Total Hip Arthroplasty
por: Gerry, Adam S., et al.
Publicado: (2022)